Predictive values of clinical and pathological parameters for malignancy of gastrointestinal stromal tumors.
暂无分享,去创建一个
W. Qi | J. Hou | Y. Ji | J. Xu | Y-S Tan | S.-H. Lu | Y. Hou | Y. Zhou | Y. Shi | X-Z. Zhu | X-Z Zhu | Y. Shi
[1] J. Lasota,et al. Gastrointestinal stromal tumours. , 1998, Annales chirurgiae et gynaecologiae.
[2] J. Fletcher,et al. Gastrointestinal stromal tumors , 2010, Virchows Archiv.
[3] S. Hirota,et al. An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors , 2007, International Journal of Clinical Oncology.
[4] Chien-Feng Li,et al. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome. , 2007, Surgery.
[5] S. Eccles,et al. Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.
[6] Y. Avni,et al. The Cyclin-Dependent Kinase Inhibitor, p27kip1, Has No Correlation with the Malignant Potential of GIST , 2007, Digestion.
[7] J. Royster. AGAI technical review statements regarding GIST are troubling. , 2007, Gastroenterology.
[8] Y. Ji,et al. Schwannoma of the gastrointestinal tract: a clinicopathological, immunohistochemical and ultrastructural study of 33 cases , 2006, Histopathology.
[9] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Jejunum and Ileum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 906 Cases Before Imatinib With Long-term Follow-up , 2006, The American journal of surgical pathology.
[10] Y. Oda,et al. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. , 2005, Human pathology.
[11] B. Nilsson,et al. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era , 2005, Cancer.
[12] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up , 2005, The American journal of surgical pathology.
[13] Huichang Yan,et al. Prognostic Assessment of Gastrointestinal Stromal Tumor , 2003, American journal of clinical oncology.
[14] Y. Nakanishi,et al. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients , 2003, Gastric Cancer.
[15] S. Hirohashi,et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. , 2002, Human pathology.
[16] J. Goldblum,et al. Gastric Stromal Tumors: A Clinicopathologic Study of 77 Cases With Correlation of Features With Nonaggressive and Aggressive Clinical Behaviors , 2002, The American journal of surgical pathology.
[17] L. Sobin,et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.
[18] W. El-Rifai,et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. , 2002, Human pathology.
[19] L. Sobin,et al. Gastrointestinal Stromal Tumors and Leiomyosarcomas in the Colon: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases , 2000, The American journal of surgical pathology.
[20] L. Sobin,et al. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. , 2000, The American journal of surgical pathology.
[21] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[22] J. Goldblum,et al. Stromal tumors of the abdominal colon: a clinicopathologic study of 20 cases. , 1999, The American journal of surgical pathology.
[23] J. Goldblum,et al. Stromal tumors of the anorectum: a clinicopathologic study of 22 cases. , 1999, The American journal of surgical pathology.
[24] J. Rodríguez-Peralto,et al. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. , 1997, Human pathology.
[25] A. Ochiai,et al. Reevaluation of prognostic factors in gastric leiomyosarcoma. , 1995, The American journal of gastroenterology.
[26] M. Miettinen,et al. Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. , 1995, The American journal of surgical pathology.
[27] S. Haque,et al. Stromal neoplasms of the rectum and anal canal. , 1992, Human pathology.
[28] M. Enjoji,et al. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors , 1992, Cancer.
[29] P. Quirke,et al. A Flow Cytometric, Clinical, and Histological Study of Stromal Neoplasms of the Gastrointestinal Tract , 1992, The American journal of surgical pathology.
[30] C. Compton,et al. Benign Smooth Muscle Tumors of the Gastrointestinal Tract: A 24‐Year Experience , 1990, Annals of surgery.
[31] M. Miettinen,et al. Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation. , 1988, American journal of clinical pathology.
[32] G. Parker,et al. Gastrointestinal sarcomas. Analysis of prognostic factors. , 1987, Annals of surgery.
[33] H. Evans. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years , 1985, Cancer.
[34] R. Buxton. Smooth muscle tumors of the gastrointestinal tract. , 1960, The American surgeon.
[35] J. Goldblum,et al. Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. , 1995, The American journal of surgical pathology.
[36] G. Farr,et al. Myosarcomas of the stomach: Natural history, prognostic factors and management , 1982, Cancer.